Gemtesa is a medication approved for the treatment of overactive bladder (OOB) with symptoms of urgency, frequency, and incontinence [1]. In Mexico, Gemtesa is known by the brand name Gevok [2].
What is Gevok (Gemtesa) used for in Mexico?
In Mexico, Gevok is prescribed to treat adult patients who experience symptoms of overactive bladder (OOB). These symptoms include urinary urgency, increased urinary frequency, and urgency urinary incontinence [2].
How does Gevok (Gemtesa) work?
Gevok contains the active ingredient vibegron, which is a selective beta-3 adrenergic agonist [1]. It works by relaxing the detrusor muscle in the bladder. This relaxation allows the bladder to hold more urine and reduces the involuntary contractions that cause OOB symptoms [1][3].
When did Gemtesa become available in Mexico?
Information on the specific market entry date for Gevok (Gemtesa) in Mexico is not readily available in the provided text. However, Gemtesa was approved by the U.S. Food and Drug Administration (FDA) in December 2019 [1].
What is the difference between Gemtesa and other OOB treatments?
Gemtesa is a beta-3 adrenergic agonist [1]. Other treatments for OOB include anticholinergic medications, which work by blocking acetylcholine receptors in the bladder to reduce muscle contractions [4]. Vibegron, the active ingredient in Gemtesa, offers a different mechanism of action that may have a different side effect profile compared to anticholinergics [1][4].
What are the side effects of Gevok (Gemtesa)?
Common side effects reported for Gemtesa include headache, nasopharyngitis (common cold symptoms), diarrhea, nausea, and upper respiratory tract infection [1].
Can Gemtesa be used by both men and women?
Yes, Gemtesa is approved for the treatment of OOB in adult patients, encompassing both men and women [1][2].
Are there any drug interactions with Gevok (Gemtesa)?
When Gevok (Gemtesa) is taken with certain medications, such as digoxin, it may affect drug levels. It is important to inform a healthcare provider about all medications being taken [1].
What is the typical dosage for Gevok (Gemtesa)?
The recommended dosage for Gemtesa is 75 mg taken once daily [1].
Where can I find information on Gemtesa patents in Mexico?
Information regarding specific patent filings and expiry dates for Gemtesa (vibegron) in Mexico would typically be available through patent databases. DrugPatentWatch.com is a resource that tracks drug patents globally [5].
What is the active ingredient in Gemtesa?
The active ingredient in Gemtesa is vibegron [1].
Sources:
[1] https://www.gemtesa.com/
[2] https://www.drugpatentwatch.com/drugs/vibegron
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023978/
[4] https://www.mayoclinic.org/diseases-conditions/overactive-bladder/diagnosis-treatment/drc-20355715
[5] https://www.drugpatentwatch.com/